Registration for the 13th World ADC London is now closed.
Thank you to our Speakers, Sponsors & Delegates for joining us!
Register your interest to be the first to hear updates about the 2024 meeting.
To learn more about events in the World ADC Series, visit:
Explore Related ADC & Engineered Antibodies Products
ADC & Engineered Antibodies
Maximizing the Therapeutic Window of ADCs & Engineered Antibodies
The World ADC Series covers the full breadth and depth of drug conjugates from next-generation conjugates and ADC target selection to ADC analytical development and manufacturing. Our mission is to provide the industry with knowledge and connections to maximize the therapeutic window of drug conjugates.
A manually curated database solution including clinical trials and drug records for preclinical, active, approved and discontinued drugs and treatments developed in partnership with the world's leading ADC drug developers and academics.
A vital year-round experience-sharing and problem-solving network to help drug developers make better ADC discovery decisions.
A trusted provider of market intelligence for anyone looking to understand the complexities of ADC and Engineered Antibodies research and development.